To carry out industrial production should be the best way out and choice for in-hospital preparation.

With the development of China's pharmaceutical industry, out of the hospital, industrialized production, should be the best way out and choice of in-hospital preparations, is also the best way to solve its survival dilemma. However, the reality is that a large number of in-hospital preparations are still confined within the hospital.

At present, many inexpensive and effective hospital-made special drugs are facing or have faced discontinuation of production. In response to this phenomenon, the newspaper's special observer, Lito Management Consultants Limited pharmaceutical enterprise management consultant Yang Tao analysis, in-hospital preparations, hospital-made special drugs and inexpensive and effective, the association between the three must have a scientific basis, why is the in-hospital preparations? Why is there no industrial industrial production? Why must in-hospital preparations be sold in their own hospitals? It is because in-hospital preparations have not undergone rigorous pharmacological, toxicological, and rigorous clinical trials. In order to control the risk to a limited extent, in-hospital preparations cannot be approved as official drugs and sold nationwide or even globally.

The industry believes that there are still two problems that need to be solved in order to bring in-hospital preparations to the market: firstly, the review of in-hospital preparations, which is difficult to adapt to the modern new drug development review system, should take efficacy and safety as the core point and establish a new clinically oriented evaluation method to build a new drug development model suitable for Chinese drug preparations; secondly, the intellectual property issue, there is a pull of interests of patent rights between prescribers, hospitals and enterprises, and there is a lack of basic regulation.